Aimee Luck Murphy has been promoted to vice president of clinical development and operations at Aduro Biotech, Inc.   Ms. Murphy began consulting for Aduro on the LADD program in 2009. She joined the company as director of clinical operations in 2011 and was promoted to senior director of clinical development and operations in 2013. Prior to Aduro, Ms. Murphy advanced the development of the LADD platform at both Cerus Corp. and Anza Therapeutics, where she managed the first Phase I studies to ...